Discontinued — last reported Q4 '22
Thermo Fisher Scientific Analytical Instruments — CapEx remained flat by 0.0% to $35.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric grew by 77.2%, from $19.75M to $35.00M.
An increase suggests investment in future growth and capacity, while a decrease may indicate a focus on cash preservation or reduced capital intensity.
This metric measures the cash outflows used by the analytical instruments segment to acquire, upgrade, and maintain phys...
Standard across all capital-intensive industries, typically found in the segment cash flow or capital expenditure disclosures.
tmo_segment_analytical_instruments_capital_expenditures| FY'21 | FY'22 | |
|---|---|---|
| Value | $79.00M | $140.00M |
| YoY Change | — | +77.2% |